BMS
AI Frontier: BMS Deepens NVIDIA Partnership for Rapid Drug Innovation
Bristol Myers Squibb (BMS), a global biopharmaceutical leader, has announced a significant expansion of its strategic artificial intelligence partnership with NVIDIA, a pioneer in accelerated computing. This enhanced collaboration is set to revolutionize the drug discovery and development process, aiming to deliver life-changing therapies to patients faster by leveraging advanced